In parallel to transcriptomic alteration, recent studies have identified genomic landmarks of recurrent glioblastomas, including the increased TMZ-induced mutagenesis and the mutations in RB and Akt-mTOR pathways [43]. Here, MTOR is linked to glioblastoma.